- Home
- OKUR vs DYAI Comparison
OKUR vs DYAI Comparison
Compare OKUR & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OKUR
- DYAI
- Stock Information
- Founded
- OKUR 2011
- DYAI 1979
- Country
- OKUR United States
- DYAI United States
- Employees
- OKUR N/A
- DYAI N/A
- Industry
- OKUR
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OKUR
- DYAI Health Care
- Exchange
- OKUR NYSE
- DYAI Nasdaq
- Market Cap
- OKUR 34.9M
- DYAI 29.6M
- IPO Year
- OKUR N/A
- DYAI 2004
- Fundamental
- Price
- OKUR $2.35
- DYAI $0.91
- Analyst Decision
- OKUR Strong Buy
- DYAI Strong Buy
- Analyst Count
- OKUR 4
- DYAI 1
- Target Price
- OKUR $32.25
- DYAI $6.00
- AVG Volume (30 Days)
- OKUR 118.8K
- DYAI 36.6K
- Earning Date
- OKUR 08-14-2025
- DYAI 08-12-2025
- Dividend Yield
- OKUR N/A
- DYAI N/A
- EPS Growth
- OKUR N/A
- DYAI N/A
- EPS
- OKUR N/A
- DYAI N/A
- Revenue
- OKUR N/A
- DYAI $3,554,344.00
- Revenue This Year
- OKUR N/A
- DYAI $22.56
- Revenue Next Year
- OKUR N/A
- DYAI $30.95
- P/E Ratio
- OKUR N/A
- DYAI N/A
- Revenue Growth
- OKUR N/A
- DYAI 57.59
- 52 Week Low
- OKUR $1.70
- DYAI $0.91
- 52 Week High
- OKUR $20.00
- DYAI $2.20
- Technical
- Relative Strength Index (RSI)
- OKUR N/A
- DYAI 37.33
- Support Level
- OKUR N/A
- DYAI $0.95
- Resistance Level
- OKUR N/A
- DYAI $1.03
- Average True Range (ATR)
- OKUR 0.00
- DYAI 0.07
- MACD
- OKUR 0.00
- DYAI 0.00
- Stochastic Oscillator
- OKUR 0.00
- DYAI 1.25
About OKUR ONKURE THERAPEUTICS INC
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. The company operates in one operating segment which is clinical research. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.